Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense oligonucleotide therapy targeting tau for Alzheimer’s disease treatment. In December 2019,

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind. Earlier diagnosis would mean that people could take advantage of the drugs sooner, when the medicines are most effective.

Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can serve as an early warning sign for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, chronic traumatic encephalopathy, and traumatic brain injury.

The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather than a one-time discussion or lesson. Be sure to acknowledge any feelings or fears he may be experiencing as he continues to witness his loved one’s progression of the disease and allow him to talk openly and freely about it.

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a study by researchers at Washington University School of Medicine in St.

31, 2025 — New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer's disease over

Understand the significance of the Alzheimer's smell test in early detection of Alzheimer's, even for remote populations.

While Alzheimer’s disease is typically marked by a slow decline in memory and cognitive ability over a number of years, a small subset of patients faces a

At the same time, shifts were seen in proteins tied to Alzheimer's, including amyloid beta and tau. These proteins often build up in brains affected by the disease. Martens pointed out that this link between NAD+ and brain proteins suggests NR might affect ...

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve cognitive functioning and memory, anew review suggests.

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.